Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

completed250%
unknown125%
withdrawn125%

Recent Activity

0 active trials
Showing 4 of 4
withdrawnnot_applicable

Foot Neuromodulation for Overactive Bladder in Children

NCT02320201
unknownnot_applicable

Predicting Central Pain Among People With a Spinal Cord Injury by Evaluating Mechanisms Regulating Pain and Efficacy Testing of the TENS Apparatus

NCT01726881
completednot_applicable

Foot Neuromodulation for Nocturnal Enuresis

NCT02315560
completedphase_1

Trigeminal Nerve Stimulation for Post Traumatic Stress Disorder (PTSD) and Depression

NCT01335217

Clinical Trials (4)

Showing 4 of 4 trials
NCT02320201Not Applicable

Foot Neuromodulation for Overactive Bladder in Children

Withdrawn
NCT01726881Not Applicable

Predicting Central Pain Among People With a Spinal Cord Injury by Evaluating Mechanisms Regulating Pain and Efficacy Testing of the TENS Apparatus

Unknown
NCT02315560Not Applicable

Foot Neuromodulation for Nocturnal Enuresis

Completed
NCT01335217Phase 1

Trigeminal Nerve Stimulation for Post Traumatic Stress Disorder (PTSD) and Depression

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4